Dubai Pharmacy College Highlights Research Excellence with Publication on Alzheimer's Therapy
April 2024 - Dubai Pharmacy College for Girls continues to demonstrate its commitment to cutting-edge research with the recent publication of a review article led by Dr. Semira Beshir and her coauthors. The article, titled "Advancements and Challenges in Anti-amyloid Therapy for Alzheimer's Disease (AD)," was published in the prestigious International Journal of Alzheimer's Disease, a Q2 journal with a 2023 Scopus cite score of 10.1.
The review centers on Alzheimer's disease (AD), a critical area of research in neurodegenerative disorders. It highlights the advancements in anti-amyloid therapy, particularly focusing on the breakthrough drug lecanemab, which has been approved for treating early AD and mild cognitive impairment (MCI). The work not only offers new hope for patients by discussing the potential of lecanemab to slow cognitive decline but also underscores the importance of continued innovation.
Dr. Beshir and her coauthors explore key challenges that still need to be addressed, including the drug's administration, the need for imaging and genetic testing, affordability concerns, and the potential for side effects. This publication reflects Dubai Pharmacy College’s dedication to advancing healthcare through impactful research.
This achievement underscores the college’s role as a leader in the field of pharmaceutical education and research, contributing valuable insights to the global fight against Alzheimer's disease.
